A detailed history of Black Diamond Wealth Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Black Diamond Wealth Management Inc. holds 1,940 shares of ABBV stock, worth $395,507. This represents 0.24% of its overall portfolio holdings.

Number of Shares
1,940
Previous 1,527 27.05%
Holding current value
$395,507
Previous $278,000 19.42%
% of portfolio
0.24%
Previous 0.23%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $63,928 - $74,653
413 Added 27.05%
1,940 $332,000
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $3,835 - $4,370
-24 Reduced 1.55%
1,527 $278,000
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $213,417 - $240,358
1,551 New
1,551 $240,000
Q1 2023

May 02, 2023

BUY
$144.61 - $166.54 $2,892 - $3,330
20 Added 1.58%
1,287 $205,000
Q4 2022

Jan 17, 2023

BUY
$138.31 - $165.87 $175,238 - $210,157
1,267 New
1,267 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Black Diamond Wealth Management Inc. Portfolio

Follow Black Diamond Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Diamond Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Diamond Wealth Management Inc. with notifications on news.